89BIO (ETNB) Competitors

89BIO (NASDAQ:ETNB) and Nuvalent (NASDAQ:NUVL) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation and profitability.

Which has more volatility & risk, ETNB or NUVL?

89BIO has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Comparatively, Nuvalent has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500.

Does the media prefer ETNB or NUVL?

In the previous week, 89BIO had 3 more articles in the media than Nuvalent. MarketBeat recorded 15 mentions for 89BIO and 12 mentions for Nuvalent. 89BIO's average media sentiment score of 0.33 beat Nuvalent's score of 0.16 indicating that 89BIO is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
89BIO	5 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nuvalent	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts rate ETNB or NUVL?

89BIO currently has a consensus price target of $26.29, suggesting a potential upside of 178.60%. Nuvalent has a consensus price target of $119.60, suggesting a potential upside of 52.04%. Given 89BIO's higher possible upside, analysts plainly believe 89BIO is more favorable than Nuvalent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
89BIO	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	3.00
Nuvalent	0 Sell rating(s)	0 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	3.09

Do institutionals & insiders believe in ETNB or NUVL?

97.3% of Nuvalent shares are held by institutional investors. 2.8% of 89BIO shares are held by insiders. Comparatively, 10.2% of Nuvalent shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Is ETNB or NUVL more profitable?

Nuvalent's return on equity of -32.58% beat 89BIO's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
89BIO	N/A	-94.48%	-80.92%
Nuvalent	N/A	-32.58%	-30.14%

Which has stronger valuation and earnings, ETNB or NUVL?

Nuvalent is trading at a lower price-to-earnings ratio than 89BIO, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
89BIO	N/A	N/A	-$367.08M	-$3.61	-2.61
Nuvalent	N/A	N/A	-$260.76M	-$4.90	-16.05

Summary

Nuvalent beats 89BIO on 8 of the 14 factors compared between the two stocks.